Where does Hewmun Lau work?

Hewmun Lau is Principal at Broadview Ventures.

What check size does Hewmun Lau write?

Hewmun Lau typically writes checks of $100K – $5M.

Where did Hewmun Lau go to school?

Hewmun Lau studied at MIT Sloan School of Management (MBA); Brandeis University (Biochemistry, Biology and Economics); Harvard-MIT Division of Health Sciences and Technology (MS, Biomedical Enterprise).

Hewmun Lau

Investor

Principal at Broadview Ventures

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to Hewmun

241 people in our graph share verified history with Hewmun — schools, employers, funds. One of them is your warm intro.

Ulrik B. NielsenunlockedHewmun: together at Merrimack (2015–2019)

Hewmun: together at Navigant

×9Hewmun: together at Brandeis University

Hewmun: together at Basking Biosciences

About

Principal on the Biopharma team involved in day-to-day investment activities. Brings 15 years in life sciences with prior roles at Merrimack Pharmaceuticals and Navigant Consulting.

Contact· self-published, not guessed

h•••@broadviewventures.orgreveal

Experience

Broadview Ventures IncPrincipalcurrent2019 — presentGreater Boston
Longview VenturesPrincipalcurrent2019 — presentBoston, Massachusetts, United States
Mosanna TherapeuticsMember Board of Directorscurrent2025 — present
Basking BiosciencesBoard Observercurrent2020 — presentResearch Triangle Park, North Carolina
Antag TherapeuticsBoard Observer2020 — 2024Copenhagen, Denmark
RenovacorBoard Observer2020 — 2021Philadelphia, Pennsylvania
MerrimackDirector of Corporate Development2018 — 2019Cambridge, MA
MerrimackAssociate Director, New Product Planning and Business Development2017 — 2018Cambridge, MA
MerrimackSenior Manager, Commercial Analytics - ONIVYDE2015 — 2017Cambridge, MA
NavigantSenior Consultant (Life Sciences Practice)2012 — 2015Greater Boston
NavigantSummer Associate (Life Sciences Practice)2011Boston, MA
RXi Pharmaceuticals CorpSummer Intern2010Worcester, MA
McLean HospitalResearch Associate2007 — 2009
Millennium PharmaceuticalsResearch Assistant2006 — 2007Cambridge, MA

Skills & more

InvestmentsStrategic PlanningCardiovascular DiseaseLifesciences11Genetics4Data Analysis6Business Strategy4Drug Discovery7Financial Modeling3Life Sciences2Clinical Trials3Laboratory2

+4 more

Management ConsultingBusiness DevelopmentBiotechnologyStrategy

Languages Bahasa Malaysia · Cantonese · Mandarin

From Hewmun's professional profile.

Colleagues at Broadview Ventures

Annabel Chen-Tournoux

Investor at Broadview Ventures

Anubodh Sunny Varshney

Venture Advisor at Broadview Ventures

Benjamin Kreitman

Principal at Broadview Ventures

Christopher Colecchi

Managing Director at Broadview Ventures

Christopher de Souza

Director at Broadview Ventures

Daniel Gottlieb

Director at Broadview Ventures

David Milan

Chief Scientific Officer, Leducq Corp at Broadview Ventures

David Prim

Principal at Broadview Ventures

Frequently asked questions

Who is Hewmun Lau?: Principal on the Biopharma team involved in day-to-day investment activities. Brings 15 years in life sciences with prior roles at Merrimack Pharmaceuticals and Navigant Consulting.
Where does Hewmun Lau work?: Hewmun Lau is Principal at Broadview Ventures.
What check size does Hewmun Lau write?: Hewmun Lau typically writes checks of $100K – $5M.
Where did Hewmun Lau go to school?: Hewmun Lau studied at MIT Sloan School of Management (MBA); Brandeis University (Biochemistry, Biology and Economics); Harvard-MIT Division of Health Sciences and Technology (MS, Biomedical Enterprise).

Same school

Also attended MIT Sloan School of Management923

Doug LeonePartner at Sequoia Capital; former Global Managing Partner Hemant TanejaCEO & Managing Director of General Catalyst Brad FeldCo-founder of Foundry and Techstars Chris MorrisProcess Specialist, Exit Readiness at Mayfair Equity Partners BirgitteInvestor at Investinor OlaInvestor at Investinor

+ 917 more

Also attended Brandeis University139

Santiago ReganDirector of Business Development at Redpoint Ventures Nicholas AdamsManaging Partner at Differential Ventures John KeiltyVenture Partner at Third Rock Ventures Kevin GillisPartner and Chief Operating Officer at Third Rock Ventures Seth LieblichInvestment Team at 8VC Alex MorganInvestor at Khosla Ventures

+ 133 more

Shared employers

Also worked at Antag Therapeutics12

Iqbal MuftiOperating Partner - Portfolio Business Development at SR One Capital Management Lene GerlachVenture Partner at Hadean Ventures Emmanuelle CoutanceauPartner at Novo Holdings Jørgen Søberg PetersenSenior Partner at Novo Holdings Jeroen BakkerPartner at Novo Holdings Thomas NeedhamDirector, Head of the Biopharma Practice at Broadview Ventures

+ 6 more

Also worked at Renovacor3

Thomas NeedhamDirector, Head of the Biopharma Practice at Broadview Ventures Marc SemigranInvestor at Broadview Ventures Matt KilleenChief Business Officer at Thryvtrx

Also worked at Merrimack8

Ulrik B. NielsenGeneral Partner at Mission Biocapital Michael LeeManaging Director at Syngenta Group Ventures Thomas NeedhamDirector, Head of the Biopharma Practice at Broadview Ventures Edward Tad StewartChief Business Officer at Matrisome Bio Michael CardoneExecutive Officer, Director at Eutropics Pharmaceuticals Istvan MolnarExecutive Officer at Radionetics Oncology

+ 2 more

Also worked at Navigant55

Kate WilschutzChief Financial Officer, Revolution Funds at Revolution Monal MehtaVenture Partner at Versant Ventures Robb HutchinsPartner, Portfolio Growth at Jump Capital Maggie RodneyPartner at Massive Christina HangSr. Research Analyst at Sands Capital Ventures Smita ChowdhriController, Public Equity at Sofinnova Ventures

+ 49 more